• EZ Cap EGFP mRNA 5-moUTP: Optimized Workflows and Applicatio

  2026-05-30

  EZ Cap™ EGFP mRNA (5-moUTP) unlocks robust, immune-evasive protein expression for advanced gene regulation, imaging, and mRNA delivery assays. This guide details experimental workflows, troubleshooting, and actionable insights from recent machine learning-driven delivery breakthroughs.

• DeferoxamineB: Protocol Innovations in Cancer Research Assay

  2026-05-29

  Deferoxamine (DeferoxamineB) is more than a conventional iron chelator—its ability to modulate ferroptosis, cuproptosis, and antitumor immunity enables advanced metabolic intervention strategies in cancer models. This article translates breakthrough findings and real-world troubleshooting into actionable protocols, ensuring researchers extract maximal value from DeferoxamineB in regulated cell death and immunometabolic studies.

• Nystatin (Fungicidin): Unraveling Advanced Antifungal Mechan

  2026-05-29

  Explore the advanced molecular actions of Nystatin (Fungicidin) against Candida and Aspergillus species, with a focus on resistance, cell adhesion, and translational boundaries. This article delivers a unique, research-driven perspective rooted in mechanistic insights and evidence-based assay strategy.

• Quinolone–Coumarin Hybrids and Novobiocin Against Toxoplasma

  2026-05-28

  This study introduces quinolone–coumarin hybrids derived from fluoroquinolones and the aminocoumarin antibiotic Novobiocin as potent antiparasitic agents against Toxoplasma gondii. The findings highlight specific hybrids and Novobiocin itself as promising candidates for safer, selective anti-Toxoplasma therapy, underscoring their potential for further translational research.

• DeferoxamineB: Mechanistic Precision in Iron Modulation for

  2026-05-28

  Discover how Deferoxamine (DeferoxamineB) from APExBIO uniquely enables mechanistic iron modulation in cancer research. This in-depth article explores its biochemical actions, advanced protocol strategies, and how it advances beyond existing metabolic intervention studies.

• VX-661 and Variant-Specific CFTR Rescue: From Calnexin Insig

  2026-05-27

  Explore how VX-661, a F508del CFTR corrector, enables precision modulation of CFTR variants in cystic fibrosis research. This article uniquely unpacks calnexin’s role and advanced assay strategies for next-generation study designs.

• Lactoferrin Potentiates Novobiocin Activity Against E. coli

  2026-05-27

  This study demonstrates that bovine lactoferrin significantly enhances the bactericidal activity of Novobiocin, an aminocoumarin antibiotic, against both laboratory and mastitis-associated strains of Escherichia coli. The findings suggest that combining immune components such as lactoferrin with antibiotics may help overcome intrinsic resistance in Gram-negative pathogens and inform future approaches to antibacterial resistance research.

• Bestatin (Ubenimex): Precision Aminopeptidase Inhibition in

  2026-05-26

  Bestatin (Ubenimex) is a gold-standard aminopeptidase inhibitor, transforming multidrug resistance (MDR) research and apoptosis assay workflows with unmatched selectivity and nanomolar potency. Discover protocol-driven troubleshooting strategies and innovative applications that put APExBIO’s Bestatin at the core of next-generation cancer and antimalarial studies.

• Atorvastatin: HMG-CoA Reductase Inhibitor in Research Contex

  2026-05-26

  Atorvastatin is a widely used HMG-CoA reductase inhibitor with proven efficacy in cholesterol metabolism research and cardiovascular disease models. Recent studies demonstrate its additional utility in inducing ferroptosis in hepatocellular carcinoma cells. This dossier provides a fact-based overview, supported by peer-reviewed evidence and product documentation.

• BMAL1 Phase Separation Controls Circadian Transcriptional Hu

  2026-05-25

  This study uncovers that BMAL1, a core circadian regulator, forms dynamic phase-separated nuclear condensates whose assembly and function are modulated by its N-terminal intrinsically disordered region and phosphorylation state. These biomolecular condensates serve as transcriptional hubs, providing a mechanistic basis for delayed gene activation and the robustness of circadian rhythms in mammals.

• PEDV Exploits IMPDH-Dependent Nucleotide Metabolism for Repl

  2026-05-25

  This study reveals that porcine epidemic diarrhea virus (PEDV) manipulates host IMPDH-dependent guanine nucleotide biosynthesis to enhance its replication. Both genetic and pharmacological inhibition of IMPDH, including with Merimepodib (VX-497), significantly suppress PEDV propagation, positioning IMPDH as a promising host-targeted antiviral strategy.

• Talin1–Piezo1–YAP Axis in Endothelial Inflammation and Ather

  2026-05-24

  This study elucidates how Talin1 modulates the Piezo1–YAP signaling axis to drive endothelial inflammation in atherosclerosis models. By defining the role of calcium influx in this pathway, the research highlights new opportunities for targeted anti-inflammatory intervention in vascular disease.

• Ibotenic Acid: Circuit Dissection and Precision in Pain Mode

  2026-05-23

  Explore how Ibotenic acid empowers neuroscience research as an NMDA receptor agonist, uniquely enabling precise manipulation of neural circuits for pain and neurodegeneration modeling. This article reveals advanced applications, referencing new insights into brain-to-spinal circuit control.

• Dihydroartemisinin: Advanced Protocols for Malaria & mTOR Re

  2026-05-22

  Dihydroartemisinin, a potent Artemisia plant extract, empowers researchers with precise inhibition of the mTOR signaling pathway and robust antimalarial activity. This guide details applied workflows, troubleshooting strategies, and practical insights that set APExBIO’s high-purity dihydroartemisinin apart for translational and bench research.

• Aminopeptidase Inhibitors in Next-Gen Cancer Therapy: Findin

  2026-05-22

  This review positions aminopeptidase inhibitors, especially Bestatin (Ubenimex), as key agents in next-generation cancer therapy through their mechanistic role downstream of the ubiquitin-proteasome pathway. The study synthesizes evidence on the physiological and therapeutic relevance of aminopeptidases, highlighting how selective inhibition can inform combination chemotherapy strategies.

11799 records 1/787 page Next 12345 下5页 Last page